PRMT5 and neoplasm: Initially, chemotherapy was the main form of treatment; however, currently, PRMT5 inhibitors show a significant growth inhibition on tumor cells, specifically the synthetic fragment-based MRTX9768, which binds to the PRMT5-MAT complex [52].